* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
SHSE:600129's PEG Ratio is ranked worse than 55.43% of 350
companies
in the Drug Manufacturers industry
Industry Median: 1.685
vs SHSE:600129: 2.05
Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.
Chongqing Taiji Industry (Group) Co (SHSE:600129) PEG Ratio Explanation
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.
Chongqing Taiji Industry (Group) Co PEG Ratio Related Terms
Chongqing Taiji Industry (Group) Co PEG Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Chongqing Taiji Industry (Group) Co PEG Ratio Chart
For the Drug Manufacturers - Specialty & Generic subindustry, Chongqing Taiji Industry (Group) Co's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Chongqing Taiji Industry (Group) Co PEG Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Chongqing Taiji Industry (Group) Co's PEG Ratio distribution charts can be found below:
* The bar in red indicates where Chongqing Taiji Industry (Group) Co's PEG Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
Chongqing Taiji Industry (Group) Co (SHSE:600129) has a PEG Ratio of 2.05 as of Jul. 11, 2026. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Chongqing Taiji Industry (Group) Co and its competitors. This is 30% above median its historical median of 1.58. Over the past decade, Chongqing Taiji Industry (Group) Co's PEG Ratio has ranged from 0.17 to 7.82. According to the industry distribution chart, Chongqing Taiji Industry (Group) Co ranks #194 out of 350 companies in the Drug Manufacturers industry, placing it in the top 55.4%.
Is Chongqing Taiji Industry (Group) Co's PEG Ratio too high?
Chongqing Taiji Industry (Group) Co's current PEG Ratio of 2.05 is 30% above median its 10-year median of 1.58. Over the past 10 years, this metric has ranged from a low of 0.17 to a high of 7.82. The Drug Manufacturers industry median PEG Ratio is 1.69. Chongqing Taiji Industry (Group) Co's value of 2.05 is 21.7% above this industry median. Based on the distribution chart, Chongqing Taiji Industry (Group) Co ranks #194 out of 350 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Chongqing Taiji Industry (Group) Co has a GF Score™ of 67/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Chongqing Taiji Industry (Group) Co's PEG Ratio compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Chongqing Taiji Industry (Group) Co ranks #194 out of 350 companies for PEG Ratio. This places Chongqing Taiji Industry (Group) Co in the lower half of its industry. The industry median PEG Ratio is 1.69. Chongqing Taiji Industry (Group) Co's value of 2.05 is 21.7% above this benchmark. Historically, Chongqing Taiji Industry (Group) Co's own PEG Ratio has ranged from 0.17 to 7.82 over the past decade. While the company's 10-year median is 1.58 vs. the industry median of 1.69, Chongqing Taiji Industry (Group) Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PEG Ratio for a Drug Manufacturers company?
The median PEG Ratio among Drug Manufacturers companies is 1.69, based on 350 companies in the industry. Companies in the top quartile (top 25%) have a PEG Ratio significantly above this median, while those in the bottom quartile fall well below. However, PEG Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Chongqing Taiji Industry (Group) Co's current PEG Ratio of 2.05 is 21.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PEG Ratio mean?
A high PEG Ratio can signal that a stock is expensive relative to its fundamentals. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Chongqing Taiji Industry (Group) Co and its competitors. For the Drug Manufacturers industry, the median PEG Ratio is 1.69 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Chongqing Taiji Industry (Group) Co's current PEG Ratio is 2.05, which is 30% above median its own 10-year median of 1.58. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chongqing Taiji Industry (Group) Co stock overvalued right now?
Based on GuruFocus' analysis, Chongqing Taiji Industry (Group) Co (SHSE:600129) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥20.80, compared to a current price of ¥16.58 — trading 20.3% below its estimated fair value. The current PEG Ratio is 2.05, which is 30% above median its 10-year median of 1.58 and 21.7% above the Drug Manufacturers industry median of 1.69. Chongqing Taiji Industry (Group) Co's overall GF Score™ is 67/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PEG Ratio calculated?
PEG Ratio is calculated from a company's financial statements. For Chongqing Taiji Industry (Group) Co (SHSE:600129), the current PEG Ratio is 2.05 as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Chongqing Taiji Industry (Group) Co (SHSE:600129) Overvalued in 2026?
Based on GuruFocus' analysis, Chongqing Taiji Industry (Group) Co stock appears to be undervalued.
The current stock price of ¥16.58 is trading 20.3% below its estimated GF Value™ of ¥20.80.
GuruFocus considers Chongqing Taiji Industry (Group) Co to be Modestly Undervalued.
Key valuation signals for SHSE:600129:
PEG Ratio: 2.05 (30% above median its 10-year median of 1.58)
GF Value™: ¥20.80 vs. price of ¥16.58 (20.3% below fair value)
Industry Position: 21.7% above the Drug Manufacturers median (#194 of 350)
No single metric tells the full story. See the SHSE:600129 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Chongqing Taiji Industry (Group) Co Business Description
Chongqing Taiji Industry (Group) Co Ltd is a China-based company engaged in the production and sales of Chinese and Western medicines. It is also engaged in the cultivation of medicinal herbs. Its products mainly include capsules, syrup, oral liquid, lyophilized series, tablets, infusion series, and injections. The company mainly conducts its business in domestic and overseas markets.
67GF Score
Get the complete analysis for SHSE:600129
PEG Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:600129 has been successfully added to your 
